1020412-43-4
1020412-43-4
Chemical Structure
Gardiquimod
- CAS No.: 1020412-43-4
- Formula:C17H23N5O
- Molecular Weight:313.40
IUPAC Name: 1-(4-amino-2-((ethylamino)methyl)-1H-imidazo[4,5-c]quinolin-1-yl)-2-methylpropan-2-ol
InChIKey: FHJATBIERQTCTN-UHFFFAOYSA-N
SMILES: OC(C)(C)CN1C(CNCC)=NC2=C1C3=CC=CC=C3N=C2N
Biological Activity: Gardiquimod is an imidazoline TLR7/8 agonist. Gardiquimod inhibits HIV-1 infection of macrophages and activated peripheral blood mononuclear cells (PBMCs). Gardiquimod specifically activates TLR7 at concentrations below 10 μM.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Gardiquimod | 99.78% | Gardiquimod is an imidazoline TLR7/8 agonist. Gardiquimod inhibits HIV-1 infection of macrophages and activated peripheral blood mononuclear cells (PBMCs). Gardiquimod specifically activates TLR7 at concentrations below 10 μM. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Gardiquimod (Standard) | ≥98% | Gardiquimod (Standard) is the analytical standard of Gardiquimod. This product is intended for research and analytical applications. Gardiquimod is an imidazoline TLR7/8 agonist. Gardiquimod inhibits HIV-1 infection of macrophages and activated peripheral blood mononuclear cells (PBMCs). Gardiquimod specifically activates TLR7 at concentrations below 10 μM. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
